1.) Provide the historical framework highlighting methotrexate (MTX) as a potential hepatotoxic medication.
2.) Review the theorized pathophysiologic considerations of MTX mediated hepatocyte/liver injury.
3.) Discuss the options to monitor for and detect MTX related hepatotoxicity.
4.) Review the management of MTX induced liver injury.
Location: virtual (by WebEx only)
Directions: If you are having trouble accessing WebEx, please contact Isaac Smith at firstname.lastname@example.org.
Meeting Number/Access Code: 470 543 135 (you will not need this if you use link above)
Call-in number: 1-650-479-3207